{
    "id": 3531,
    "fullName": "MTOR L2230V",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "MTOR L2230V lies within the PI3K/PI4K domain of the Mtor protein (UniProt.org). L2230V has been demonstrated to result in increased kinase activity towards S6K in vitro relative to wild-type Mtor (PMID: 27482884).",
            "references": [
                {
                    "id": 6761,
                    "pubMedId": 27482884,
                    "title": "Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27482884"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2475,
        "geneSymbol": "MTOR",
        "terms": [
            "MTOR",
            "FRAP",
            "FRAP1",
            "FRAP2",
            "RAFT1",
            "RAPT1",
            "SKS"
        ]
    },
    "variant": "L2230V",
    "createDate": "03/05/2015",
    "updateDate": "06/16/2017",
    "referenceTranscriptCoordinates": {
        "id": 145315,
        "transcript": "NM_004958",
        "gDna": "chr1:g.11122101A>C",
        "cDna": "c.6688T>G",
        "protein": "p.L2230V",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8829,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing MTOR L2230V treated with Rapamune (sirolimus) in culture demonstrated decreased phosphorylation of S6k, suggesting sensitivity (PMID: 27482884).",
            "molecularProfile": {
                "id": 3338,
                "profileName": "MTOR L2230V"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6761,
                    "pubMedId": 27482884,
                    "title": "Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27482884"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8830,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing the double mutant, MTOR F1888L and MTOR L2230V, demonstrated resistance to Rapamune (sirolimus) in culture (PMID: 27482884).",
            "molecularProfile": {
                "id": 26458,
                "profileName": "MTOR F1888L MTOR L2230V"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6761,
                    "pubMedId": 27482884,
                    "title": "Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27482884"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3338,
            "profileName": "MTOR L2230V",
            "profileTreatmentApproaches": [
                {
                    "id": 16700,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "MTOR L2230V"
                },
                {
                    "id": 16699,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "MTOR L2230V"
                },
                {
                    "id": 16698,
                    "name": "mTOR Inhibitor",
                    "profileName": "MTOR L2230V"
                }
            ]
        },
        {
            "id": 26458,
            "profileName": "MTOR F1888L MTOR L2230V",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 145316,
            "transcript": "XM_005263438",
            "gDna": "chr1:g.11122101A>C",
            "cDna": "c.6688T>G",
            "protein": "p.L2230V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 145315,
            "transcript": "NM_004958",
            "gDna": "chr1:g.11122101A>C",
            "cDna": "c.6688T>G",
            "protein": "p.L2230V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}